Recent advances in nanoscale metal-organic frameworks for cancer chemodynamic therapy

Nanoscale. 2023 May 25;15(20):8948-8971. doi: 10.1039/d3nr00867c.

Abstract

Chemodynamic therapy (CDT), a novel therapeutic approach based on Fenton (Fenton-like) reaction, has been widely employed for tumor therapy. This approach utilizes Fe, Cu, or other metal ions (Mn, Zn, Co, or Mo) to react with the excess hydrogen peroxide (H2O2) in tumor microenvironments (TME), and form highly cytotoxic hydroxyl radical (˙OH) to kill cancer cells. Recently, nanoscale metal-organic frameworks (nMOFs) have attracted considerable attention as promising CDT agents with the rapid development of cancer CDT. This review focuses on summarizing the latest advances (2020-2022) on the design of nMOFs as nanomedicine for CDT or combination therapy of CDT and other therapies. The future development and challenges of CDT are also proposed based on recent progress. Our group hopes that this review will enlighten the research and development of nMOFs for CDT.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Cell Line, Tumor
  • Humans
  • Hydrogen Peroxide / therapeutic use
  • Metal-Organic Frameworks* / pharmacology
  • Metal-Organic Frameworks* / therapeutic use
  • Metals
  • Neoplasms* / drug therapy
  • Tumor Microenvironment

Substances

  • Metal-Organic Frameworks
  • Hydrogen Peroxide
  • Antineoplastic Agents
  • Metals